Valuation : Raia Drogasil S.A.

Market Cap 34.2B 6.7B 5.77B 5.47B 4.96B 9.3B 640B 9.35B 64.94B 24.97B 326B 25.17B 24.62B 1,029B P/E 2026 *
22.8x
P/E 2027 * 17.2x
Enterprise Value 42.48B 8.33B 7.17B 6.79B 6.16B 11.55B 795B 11.61B 80.67B 31.02B 405B 31.27B 30.58B 1,279B EV / Sales 2026 *
0.93x
EV / Sales 2027 * 0.83x
Free-Float
73.16%
Yield 2026 *
1.89%
Yield 2027 * 2.21%
1 day-1.36%
1 week-2.15%
Current month-0.20%
1 month+8.67%
3 months+12.03%
6 months-17.29%
Current year-16.59%
1 week 19.31
Extreme 19.31
20.52
1 month 16.93
Extreme 16.93
20.73
Current year 16.21
Extreme 16.21
27.42
1 year 16.21
Extreme 16.21
27.42
3 years 12.81
Extreme 12.813725
29.8
5 years 12.81
Extreme 12.813725
29.8
10 years 10.42
Extreme 10.418549
29.8
Manager TitleAgeSince
Chief Executive Officer 50 2024-12-31
Director of Finance/CFO 63 2013-04-28
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 50 2024-12-31
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
5/29/26 Others -91,227 0.0052% -
5/28/26 Others -352,797 0.0201%
5/27/26 Others 351,489 0.0201%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-2.15%+10.47%-28.10% 6.7B
-0.71%-4.46%-14.97%+29.23% 1.34B
-0.86%-3.59%+6.49%+12.65% 538M
-0.25%-0.57%-7.38%+28.60% 68.58M
Average -0.80%-2.69%-1.35%+10.59% 2.16B
Weighted average by Cap. -1.22%-2.59%+6.14%-16.23%

Financials

2026 *2027 *
Net sales 45.45B 8.91B 7.67B 7.27B 6.59B 12.36B 851B 12.42B 86.31B 33.19B 433B 33.45B 32.72B 1,368B 52B 10.19B 8.78B 8.31B 7.54B 14.14B 974B 14.21B 98.74B 37.97B 495B 38.27B 37.43B 1,565B
Net income 1.51B 296M 255M 241M 219M 410M 28.26B 412M 2.87B 1.1B 14.38B 1.11B 1.09B 45.44B 2.02B 396M 341M 323M 293M 549M 37.84B 552M 3.84B 1.48B 19.25B 1.49B 1.45B 60.83B
Net Debt 8.28B 1.62B 1.4B 1.32B 1.2B 2.25B 155B 2.26B 15.73B 6.05B 78.89B 6.1B 5.96B 249B 8.97B 1.76B 1.52B 1.43B 1.3B 2.44B 168B 2.45B 17.04B 6.55B 85.47B 6.6B 6.46B 270B
Logo Raia Drogasil S.A.
Raia Drogasil S.A. specializes in the distribution of medicines, cosmetics and dermocosmetics, perfumery, personal care and beauty products. Net sales break down by family of products as follows: - branded pharmaceuticals (42%); - pharmaceutical additives (25.1%) ; - OTC products (21.3%); - generic pharmaceutical products (11.4%). At the end of 2020, its products were marketed through a network of 2,299 pharmacies under the Drogasil (1,304) and Raia (995) brands in Brazil.
Employees
75,594
Date Price Change Volume
26-09-11 R$19.56 -1.01% 4,677,400
26-09-10 R$19.76 +0.82% 14,160,100
26-09-09 R$19.60 -4.02% 6,591,900
26-09-08 R$20.42 +2.15% 6,827,800
26-09-04 R$19.99 -1.38% 4,581,700
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
19.56BRL
Average target price
25.45BRL
Spread / Average Target
+30.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RADL3 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!